Ona Therapeutics's $86.6M Series B: Barcelona's ADC Cancer Bet
Barcelona biopharma Ona Therapeutics closed an oversubscribed $86.6M Series B in June 2026 to advance first-in-class antibody-drug conjugates for resistant cancers.
Healthtech Venture Capital & Digital Health Funding
Healthtech venture capital spans digital health platforms, care delivery innovation, diagnostics, and AI-enabled clinical workflows. Our healthtech coverage tracks the funding rounds and fund strategies defining the next generation of healthcare technology.
Healthtech VC Themes
- Digital health: Telehealth, care navigation, and patient engagement
- AI in healthcare: Clinical decision support, documentation, and operations
- Biopharma adjacencies: Drug discovery tools and life-sciences infrastructure
- Payer & provider tech: Revenue cycle, benefits, and workforce solutions
Browse healthtech venture capital articles below.
Related Articles (18 articles)
Semble's £30M Series C: Modern Software for Healthcare Providers
UK healthcare-tech company Semble raised a £30M Series C led by Revaia in June 2026, scaling its practice-management platform for clinicians.
Garner Health's $100M Series E at $2.74B: Data-Driven Provider Selection
Garner Health raised $100M Series E led by Index Ventures in May 2026 at a $2.74B valuation, scaling its data platform for finding high-quality healthcare providers.
MiRus's $1.5B: A Medtech Megaround in an AI-Dominated Market
MiRus raised $1.5B in May 2026, one of the month's largest non-AI rounds, underscoring that medical devices can still command megaround capital.
Nourish's $100M Series C: Dietitian-Led Metabolic Health Hits $215M Total Funding
Nourish closed $100M Series C in NYC — the country's largest dietitian-led metabolic health clinic scales virtual care with real clinical outcomes.
Century Health's $5M Seed: 97% Clinical Abstraction Accuracy Is the Headline That Matters
Century Health raised $5M seed in NYC — CHARM model hits 97% accuracy on clinical data abstraction for life sciences R&D.